Innovation comes at a price, one that health insurers may hesitate to pay. While some patients reap a benefit from breakthrough drugs, others do not. So how can insurers reduce their financial risk and give patients access to the innovative prescription drugs their doctor prescribes? A new video from Alliance for Patient Access explores one intriguing option: value-based contracting.